← Human Trials & Peer-Reviewed Studies
Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study.
Plain-language guide to PMID 8028511 (1994): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 10 women.
Key Facts
- PMID
- 8028511
- Journal
- Metabolism: clinical and experimental
- Year
- 1994
- Study type
- Randomized Controlled Trial
- Authors
- Jørgensen JO et al. (7 authors)
- DOI
- 10.1016/0026-0495(94)90269-0
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Growth hormone (GH) promotes protein anabolism and lipolysis.
In addition, GH stimulates energy expenditure (EE) and peripheral thyroid hormone metabolism.
Who Took Part
According to the abstract, 10 women were involved.
PubMed indexes the participants as adults, women only.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.
Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.
Each person switched between Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and the comparison at some point, usually with a gap in between.
What Was Measured
PubMed files the paper under topics including Blood Glucose, Calorimetry, Indirect, Energy Metabolism, Glucose Clamp Technique, Growth Hormone, Obesity and Proteins.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 10 women.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 1994 (Metabolism: clinical and experimental), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.